SCUEL — Japan healthcare data

HomeTherapeutic areas › Estrogens and progestogens

Japan market screening · Therapeutic class

Estrogens and progestogens in Japan

卵胞ホルモン及び黄体ホルモン剤 · Japan Standard Commodity Classification

12 molecules in this class are marketed in Japan across 41 products. 10 of those products are not shipping normally today — 24.4% of the class. Supply status is reported to the Ministry of Health, Labour and Welfare and updated daily.

12Molecules
41Marketed products
10Products constrained

Molecules in this class

Ordered by how many products compete. Constrained means limited supply or supply suspended; supply suspended does not mean discontinued.

MoleculeProducts CompaniesConstrained Supply mix
Estradiolエストラジオール84
Estriolエストリオール73
Medroxyprogesterone Acetateメドロキシプロゲステロン酢酸エステル746
Progesteroneプロゲステロン65
Chlormadinone Acetateクロルマジノン酢酸エステル54
Estradiol Valerateエストラジオール吉草酸エステル222
Dydrogesteroneジドロゲステロン11
Estrogens, Conjugated結合型エストロゲン11
Ethinylestradiolエチニルエストラジオール11
Gestonorone Caproateゲストノロンカプロン酸エステル111
Hydroxyprogesterone Caproateヒドロキシプロゲステロンカプロン酸エステル111
Norethisteroneノルエチステロン11
Normal supply Limited supply Supply suspended

How to read this

Products counts every marketed product across all strengths and forms, not companies. Companies is the number of companies marketing that molecule; the same company may appear under several molecules, so the column does not add up to a class total. Market size sits on each molecule's own page, valued at national price rather than transaction price. Figures are as at 2026-08-28.

Screening this area in Japan?

Tell us which molecules matter to you. We will tell you what the public data can and cannot answer before you commission anything.

Send an enquiry

Our Database Division replies in English within three business days (Japan time).